Chemistry for peptide and protein PEGylation

Walsh, 2000, Biopharmaceutical benchmarks, Nat. Biotechnol., 18, 831, 10.1038/78720 Mateo, 2000, Removal of amphipathic epitopes from genetically engineered antibodies: production of modified immunoglobulins with reduced immunogenicity, Hybridoma, 19, 463, 10.1089/027245700750053959 Lyczak, 1994, Biological and pharmacokinetic properties of a novel immunoglobulin-CD4 fusion protein, Arch. Virol., 139, 189, 10.1007/BF01309464 Syed, 1997, Potent antithrombin activity and delayed clearance from the circulation characterize recombinant hirudin genetically fused to albumin, Blood, 89, 3243, 10.1182/blood.V89.9.3243 Cohen, 1991, Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres, Pharm. Res., 8, 713, 10.1023/A:1015841715384 Abuchowski, 1977, Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase, J. Biol. Chem., 252, 3582, 10.1016/S0021-9258(17)40292-4 1992 Harris, 1985, Synthesis of polyethylene glycol derivatives, J. Macromol. Sci. Rev. Macromol. Chem. Phys., C25, 325, 10.1080/07366578508081960 Zalipsky, 1995, Chemistry of polyethylene glycol conjugates with biologically active molecules, Adv. Drug Deliv. Rev., 16, 157, 10.1016/0169-409X(95)00023-Z Veronese, 2001, Peptide and protein PEGylation: a review of problems and solutions, Biomaterials, 22, 405, 10.1016/S0142-9612(00)00193-9 Hooftman, 1996, Review: Poly(ethylene glycol)s with reactive endgroups. II. Practical consideration for the preparation of protein–PEG conjugates, J. Bioact. Compat. Polym., 11, 135, 10.1177/088391159601100205 M.D. Bentley, J.M. Harris, A. Kozlowski, Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation, P.C.T. US99/23536 (1999). J.M. Harris, A. Kozlowski, Polyethylene glycol and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications, US Patent 5,672,662 (1997). Akiyama, 2000, Selective synthesis of heterobifunctional poly(ethylene glycol) derivatives containing both mercapto and acetal terminals, Bioconjug. Chem., 11, 947, 10.1021/bc000034w Polson, 1977, A theory for the displacement of proteins and viruses with polyethylene glycol, Prep. Biochem., 7, 129 Gombotz, 1992, Protein adsorption to and elution from polyether surfaces, 247 Abuchowski, 1977, Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol, J. Biol. Chem., 252, 3578, 10.1016/S0021-9258(17)40291-2 Working, 1997, Safety of poly(ethylene glycol) and poly(ethylene glycol) derivatives, 45 Richter, 1983, Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins, Int. Arch. Allergy Appl. Immunol., 70, 124, 10.1159/000233309 Richter, 1984, Polyethylene glycol reactive antibodies in man: titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors, Int. Arch. Allergy Appl. Immunol., 74, 36, 10.1159/000233512 Cheng, 1999, Accelerated clearance of polyethylene glycol-modified proteins by anti-polyethylene glycol IgM, Bioconjug. Chem., 10, 520, 10.1021/bc980143z Clark, 1996, Long-acting growth hormones produced by conjugation with polyethylene glycol, J. Biol. Chem., 271, 21969, 10.1074/jbc.271.36.21969 Zalipsky, 1992, Use of functionalized poly(ethylene glycol)s for modification of polypeptides, 347 Matsushima, 1980, Modification of E. Coli asparaginase with 2,4-bis(o-methoxypolyethylene glycol)-6-chloro-s-triazine (activated PEG2); disappearance of binding ability towards anti-serum and retention of enzymatic activity, Chem. Lett., 773, 10.1246/cl.1980.773 Francis, 1998, PEGylation of cytokines and other therapeutic proteins and peptides: the importance of biological optimization of coupling techniques, Int. J. Hematol., 68, 1, 10.1016/S0925-5710(98)00039-5 Gais, 1995, Modification and immobilization of proteins with polyethylene glycol tresylates and polysaccharide tresylates: evidence suggesting a revision of the coupling mechanism and the structure of the polymer–polymer linkage, Tetrahedron Lett., 36, 3837, 10.1016/0040-4039(95)00633-N Zalipsky, 1992, Evaluation of a new reagent for covalent attachment of polyethylene glycol to proteins, Biotechnol. Appl. Biochem., 15, 100, 10.1111/j.1470-8744.1992.tb00198.x Miron, 1993, A simplified method for the preparation of succinimidyl carbonate polyethylene glycol for coupling to proteins, Bioconjug. Chem., 4, 568, 10.1021/bc00024a022 E.K. Dolence, C. Hu, R. Tsang, C.G. Sanders, S. Osaki, Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces, US Patent 5,650,234 (1997). Shearwater Corporation Catolog, 2001. S. Lee, C. McNemar, Substantially pure histidine-linked protein polymer conjugates, US Patent 5,985,263 (1999). Veronese, 1985, Activation of monomethoxy poly(ethylene glycol) by phenylchloroformate and modification of ribonuclease and superoxide dismutase, Appl. Biochem. Biotechnol., 11, 141, 10.1007/BF02798546 Beauchamp, 1983, A new procedure for the synthesis of polyethylene glycol-protein adducts, effects on function, receptor recognition and clearance of superoxide dismutase, lactoferrin and α2-macroglobulin, Anal. Biochem., 131, 25, 10.1016/0003-2697(83)90131-8 Abuchowski, 1984, Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol-asparaginase conjugates, Cancer Biochem. Biophys., 7, 175 Carter, 1985, Instability of succinyl ester linkages in O2′-monosuccinyl cyclic AMP-protein conjugates at neutral pH, J. Immunol. Methods, 81, 245, 10.1016/0022-1759(85)90210-8 J.M. Harris, R.M. Herati, Preparation and use of polyethylene glycol propionaldehyde, US Patent 5,252,714 (1993). Kinstler, 1996, Characterization and stability of N-terminally PEGylated rhG-CSF, Pharm. Res., 13, 996, 10.1023/A:1016042220817 O.B. Kinstler, N.E. Gabriel, C.E. Farrar, R.B. DePrince, N-terminally chemically modified protein compositions and methods, US Patent 5,985,265 (1999). Edwards, 1999, PEGylated recombinant human soluble tumor necrosis factor receptor type I (rHu-sTNF-RI): A novel high-affinity TNF receptor designed for chronic inflammatory diseases, Ann. Rheum. Dis., 58, I73, 10.1136/ard.58.2008.i73 M.D. Bentley, J.M. Harris, Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying. US Patent 5,990,237 (1999). Zalipsky, 1986, Preparation of polyethylene glycol derivatives with two different functional groups at the termini, Polym. Preprints, 27, 1 Zalipsky, 1990, Facile synthesis of α-hydroxy-ω-carboxymethylpolyethylene oxide, J. Bioact. Compat. Polym., 5, 227, 10.1177/088391159000500206 Goodson, 1990, Site-directed pegylation of recombinant interleukin-2 at its glycosylation site, Biotechnology, 8, 343, 10.1038/nbt0490-343 Kogan, 1992, The synthesis of substituted methoxy-poly(ethylene glycol) derivatives suitable for selective protein modification, Synth. Commun., 22, 2417, 10.1080/00397919208019100 Morpurgo, 1996, Preparation and characterization of poly(ethylene glycol) vinyl sulfone, Bioconjug. Chem., 7, 363, 10.1021/bc9600224 Woghiren, 1993, Protected thiol-polyethylene glycol: a new activated polymer for reversible protein modification, Bioconjug. Chem., 4, 314, 10.1021/bc00023a002 N. El Tayar, M.J. Roberts, J.M. Harris, W. Sawlivich, Polyol-IFN-β conjugates, WO99/55377 (1999). Karpusas, 1997, The crystal structure of human interferon beta at 2.2-A resolution, Proc. Natl. Acad. Sci. USA, 94, 11813, 10.1073/pnas.94.22.11813 Zalipsky, 1997, Hydrazide derivatives of poly(ethylene glycol) and their bioconjugates, 318 Gaertner, 1996, Site-specific attachment of functionalized poly(ethylene glycol) to the amino terminus of proteins, Bioconjug. Chem., 7, 38, 10.1021/bc950074d Bailon, 2001, Rational design of a potent, long-lasting form of interferon: A 40 kDa branched polyethylene glycol-conjugated interferon α-2a for the treatment of hepatitis C, Bioconjug. Chem., 12, 195, 10.1021/bc000082g Harris, 2001, Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C, J. Controlled Release, 72, 217, 10.1016/S0168-3659(01)00277-2 Glue, 1999, PEG-interferon-α2b: pharmacokinetics, pharmacodynamics, safety and preliminary efficacy data, Hepatology, 30, 189AA Algranati, 1999, A branched methoxy 40 kDa polyethyleneglycol (PEG) moiety optimizes the pharmacokinetics (PK) of PEG-interferon α2a (PEG-IFN) and may explain its enhanced efficacy in chronic hepatitis C (CHC), Hepatology, 40, 190A Roberts, 1998, Attachment of degradable poly(ethylene glycol) to proteins has the potential to increase therapeutic efficacy, J. Pharm. Sci., 87, 1440, 10.1021/js9800634 Garman, 1987, The preparation and properties of novel reversible polymer–protein conjugates, FEBS Lett., 223, 361, 10.1016/0014-5793(87)80319-8 Zhao, 1999, A hydrolyzable linkage for PEG-proteins, 144 Lee, 2001, Drug delivery systems employing 1,6-elimination: Releasable poly(ethylene glycol) conjugates of proteins, Bioconjug. Chem., 12, 163, 10.1021/bc000064z Zalipsky, 1999, New detachable poly(ethylene glycol) conjugates: Cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine, Bioconjug. Chem., 10, 703, 10.1021/bc990031n M.D. Bentley, J.M. Harris, A. Kozlowski, Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation, WO 126692A1 (2001). Yokoyama, 1992, Synthesis of poly(ethylene oxide) with heterobifunctional reactive groups at its terminals by an anionic initiator, Bioconjug. Chem., 3, 275, 10.1021/bc00016a003 Cammas, 1995, Heterobifunctional poly(ethylene oxide): synthesis of alpha-methoxy-omega-amino and alpha-hydroxy-omega-amino PEOs with the same molecular weights, Bioconjug. Chem., 6, 226, 10.1021/bc00032a011 Nagasaki, 1995, Formyl-ended heterobifunctional poly(ethylene oxide): synthesis of poly(ethylene oxide) with a formyl group at one end and a hydroxyl group at the other end, Bioconjug. Chem., 6, 231, 10.1021/bc00032a012 Yamasaki, 1988, Novel polyethylene glycol derivatives for modification of proteins, Agric. Biol. Chem., 52, 2125 Monfardini, 1995, A branched monomethoxypoly(ethylene glycol) for protein modification, Bioconjug. Chem., 6, 62, 10.1021/bc00031a006 Veronese, 1997, Branched and linear poly(ethylene glycol): influence of the polymer structure on enzymological, pharmacokinetic and immunological properties of protein conjugates, J. Bioact. Compat. Polym., 12, 196, 10.1177/088391159701200303 J.M. Harris, A. Kozlowski, Poly(ethylene glycol) derivatives with proximal reactive groups, WO 99/45964 (1999). F.H. Arnold, G.E. Wuenschell, Immobilized metal aqueous two-phase extraction and precipitation, US Patent 5,283,339 (1994). A.J. Martinez, A. Pendri, R.B. Greenwald, Y.H. Choe, Terminally-branched polymeric linkers and polymeric conjugates containing the same, US Patent 6,153,655 (2000).